Omeros (OMER) Cash & Equivalents (2010 - 2026)
Omeros' (OMER) quarterly Cash & Equivalents came in at $1.9 million in Q1 2026, down 55.27% year-on-year from $4.3 million in Q1 2025, and down 80.27% quarter-over-quarter from $9.7 million in Q4 2025.
Omeros (OMER) Cash & Equivalents (2010 - 2026) Analysis & Trends
Omeros has disclosed Cash & Equivalents across 17 years of filings, most recently posting $1.9 million for Q1 2026.
- Cash & Equivalents for Q1 2026 came in at $1.9 million, down 55.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (down 55.27% YoY), and the FY2025 annual result was $9.7 million, up 184.12% from the prior year.
- Cash & Equivalents came in at $1.9 million for Q1 2026 at Omeros, down from $9.7 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $230.3 million in Q1 2024 to a low of $1.9 million in Q1 2026.
- The 5-year median for Cash & Equivalents is $11.0 million (2022), against an average of $58.8 million.
- Across the five-year window, Cash & Equivalents surged 5960.53% in 2024 and sank 98.15% in 2025, its largest moves.
- Omeros' Cash & Equivalents stood at $11.0 million in 2022, then slumped by 35.46% to $7.1 million in 2023, then sank by 52.15% to $3.4 million in 2024, then surged by 184.12% to $9.7 million in 2025, then tumbled by 80.27% to $1.9 million in 2026.
- The last three Cash & Equivalents figures came in at $1.9 million (Q1 2026), $9.7 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 1.91 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.15 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.49 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 558.94 Mn |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.91 Mn |
| Dec 31, 2025 | 9.66 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 28.70 Mn |
| Mar 31, 2025 | 4.26 Mn |
| Dec 31, 2024 | 3.40 Mn |
| Sep 30, 2024 | 123.20 Mn |
| Jun 30, 2024 | 158.90 Mn |
| Mar 31, 2024 | 230.30 Mn |
| Dec 31, 2023 | 7.11 Mn |
| Sep 30, 2023 | 30.64 Mn |
| Jun 30, 2023 | 6.60 Mn |
| Mar 31, 2023 | 3.80 Mn |
| Dec 31, 2022 | 11.01 Mn |
| Sep 30, 2022 | 221.00 Mn |
| Jun 30, 2022 | 14.10 Mn |
| Mar 31, 2022 | 142.20 Mn |
| Dec 31, 2021 | 100.81 Mn |
| Sep 30, 2021 | 7.42 Mn |
| Jun 30, 2021 | 12.70 Mn |